Emergent BioSolutions Inc. — Director's Dealing 2014

Mar 12, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2014-03-11

Reporting Person: Havey Adam (EVP, Biodefense Divison)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-03-11	Common Stock	F	1336	$28.09	Disposed	28695	Direct
2014-03-11	Common Stock	A	14060	—	Acquired	42755	Direct
2014-03-11	Common Stock	S	5835	$26.96	Disposed	36920	Direct
2014-03-11	Common Stock	M	4887	$15.83	Acquired	41807	Direct
2014-03-11	Common Stock	M	6933	$15.91	Acquired	48800	Direct
2014-03-11	Common Stock	S	11820	$26.96	Disposed	36920	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-03-11	Employee Stock Option (right to buy)	$28.09	A	28119	Acquired	2021-03-10	Common Stock (28119)	Direct
2014-03-11	Employee Stock Option (right to buy)	$15.91	M	6933	Disposed	2014-03-08	Common Stock (6933)	Direct
2014-03-11	Employee Stock Option (right to buy)	$15.83	M	4887	Disposed	2019-03-12	Common Stock (4887)	Direct

Footnotes

F1: Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan.

F2: These restricted stock units vest in three equal annual installments beginning on the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

F3: Vests in three equal installments on March 10, 2015, March 10, 2016 and March 10, 2017.

F4: The option is fully vested.

F5: The option will vest with respect to the remaining 4,887 shares on March 12, 2015.